Celebrex May Reduce Levels of Lung Cancer Biomarker
Anti-inflammatory might one day help prevent malignancies, study suggests
Posted June 1, 2008
PET imaging identified 14 percent of patients who had cancer too advanced for surgery, while conventional work-ups only identified 7 percent of such patients for whom surgery would have been inappropriate.
"PET can replace conventional tagging in early stage non-small cell lung cancer," said study investigator Dr. Donna E. Maziak, of the Ontario Clinical Oncology Group in Hamilton, Ontario.
More information
Visit the National Cancer Institute for more on lung cancer.
advertisement
